Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. China
  4. Shanghai Stock Exchange
  5. Eyebright Medical Technology (Beijing) Co., Ltd.
  6. Summary
    688050   CNE1000041J5

EYEBRIGHT MEDICAL TECHNOLOGY (BEIJING) CO., LTD.

(688050)
  Report
 SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Shanghai Stock Exchange
01/19/2022 01/20/2022 01/21/2022 01/24/2022 01/25/2022 Date
191.01 185.6 179.77 183.2 172.36 Last
902915 888065 1654196 1124320 2709134 Volume
-2.74% -2.83% -3.14% +1.91% -5.92% Change
Estimated financial data (e)
Sales 2021 423 M 66,9 M 66,9 M
Net income 2021 161 M 25,5 M 25,5 M
Net cash position 2021 404 M 63,9 M 63,9 M
P/E ratio 2021 110x
Yield 2021 0,20%
Sales 2022 632 M 99,9 M 99,9 M
Net income 2022 235 M 37,2 M 37,2 M
Net cash position 2022 130 M 20,5 M 20,5 M
P/E ratio 2022 76,4x
Yield 2022 0,20%
Capitalization 18 122 M 2 865 M 2 866 M
EV / Sales 2021 41,9x
EV / Sales 2022 28,5x
Nbr of Employees 418
Free-Float -
More Financials
Company
Eyebright Medical Technology Beijing Co Ltd is a China-based company principally involved in the research, development, manufacturing and sales of ophthalmic medical devices. Its main products include ophthalmic surgery and optometry. Surgical products mainly include intraocular lens, capsular tension ring, intraocular lens implantation system, ophthalmic viscoelastic agent, various types of ophthalmic microsurgical... 
More about the company
Ratings of Eyebright Medical Technology (Beijing) Co., Ltd.
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
-
More Ratings
All news about EYEBRIGHT MEDICAL TECHNOLOGY (BEIJING) CO., LTD.
2021Tianjin Zhengli Technology Co., Ltd. announced that it has received $15.7 million in fu..
CI
2021EYEBRIGHT MEDICAL TECHNOLOGY CO., LT : 688050) added to Shanghai Stock Exchange Health Car..
CI
2021Eyebright Medical Technology Co., Ltd. Reports Earnings Results for the Nine Months End..
CI
2021Eyebright Medical Technology Beijing Co., Ltd. Reports Earnings Results for the Half Ye..
CI
2021EYEBRIGHT MEDICAL TECHNOLOGY CO., LT : 688050) added to Shanghai Stock Exchange A Share In..
CI
2021Certain A Shares of Eyebright Medical Technology Co., Ltd. are subject to a Lock-Up Agr..
CI
2021EYEBRIGHT MEDICAL TECHNOLOGY CO., LT : 688050) added to Shanghai Stock Exchange Composite ..
CI
2021Eyebright Medical Technology Beijing Co., Ltd. Reports Earnings Results for the First Q..
CI
2021Eyebright Medical Technology Co., Ltd. entered into a framework agreement to acquire a ..
CI
2021Eyebright Medical Technology Beijing Co., Ltd. Reports Earnings Results for the Full Ye..
CI
2021Jiangsu Tianyan Pharmaceutical Technology Co., Ltd. announced that it expects to receiv..
CI
2020Eyebright Medical Technology Co., Ltd. Reports Earnings Results for the First Three Qua..
CI
2020Eyebright Medical Technology Co., Ltd. Reports Earnings for the First Half of 2020
CI
2020Eyebright Medical Technology Beijing Co., Ltd. Announces Earnings Results for the Nine ..
CI
2020Eyebright Medical Technology Co., Ltd. has completed an IPO in the amount of CNY 882 mi..
CI
More news
News in other languages on EYEBRIGHT MEDICAL TECHNOLOGY (BEIJING) CO., LTD.

- No features available -

More news
Chart EYEBRIGHT MEDICAL TECHNOLOGY (BEIJING) CO., LTD.
Duration : Period :
Eyebright Medical Technology (Beijing) Co., Ltd. Technical Analysis Chart | 688050 | CNE1000041J5 | MarketScreener
Technical analysis trends EYEBRIGHT MEDICAL TECHNOLOGY (BEIJING) CO., LTD.
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 5
Last Close Price 172,36 CNY
Average target price 307,18 CNY
Spread / Average Target 78,2%
EPS Revisions
Managers and Directors
Jiang Bing Xie Chairman, General Manager & Chief Scientist
Yan Chang Guo Chief Financial Officer & Director
Dan Xuan Wang Chairman-Supervisory Board
Zhao Wang Director-Technology, Manager-R&D
Yu Jiao Wang Administrative Assistant
Sector and Competitors
1st jan.Capi. (M$)
EYEBRIGHT MEDICAL TECHNOLOGY (BEIJING) CO., LTD.-18.01%2 865
STRAUMANN HOLDING AG-24.45%25 439
SONOVA HOLDING AG-14.81%20 755
DEMANT A/S-16.56%10 168
COCHLEAR LIMITED-10.65%9 026
ÖSSUR HF.-11.11%2 412